Skip to content

Author

Min-Young Noh

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Longitudinal CDR-Sum of Boxes trajectories in mild cognitive impairment reveal functional heterogeneity beyond cognitive decline: A latent class growth analysis

Background Mild cognitive impairment (MCI) is clinically heterogeneous, yet most prognostic studies rely on binary conversion endpoints or expensive biomarkers unavailable in routine practice. Objective To identify trajectory classes of the Clinical Dementia Rating-Sum of Boxes (CDR-SB) progression in MCI using latent...

Yeonsil Moon, S. W. Seo, Min-Young Noh et al. · 0 citations
Open access Oct 2026

miR‐214‐3p and NCKAP1: A microglial functional dimension of Alzheimer's progression

Abstract INTRODUCTION Biological Alzheimer's disease (AD) pathology does not fully explain the marked heterogeneity in clinical severity or progression. We investigated whether patient‐derived induced microglia‐like cell (iMG) profiles capture a functional dimension of AD progression beyond conventional plasma biomarke...

Min-Young Noh, Yeonsil Moon, Sung-Woo Kang et al. · 0 citations
Open access Jul 2026

Lecanemab in symptomatic PSEN1 p.Met233Val early‐onset Alzheimer's disease: Neuroimaging safety, regional amyloid‐PET dynamics, and longitudinal plasma biomarkers

The presenilin 1 (PSEN1) p.Met233Val variant is a Dominantly Inherited Alzheimer Network–Trials Unit (DIAN‐TU)–eligible autosomal‐dominant Alzheimer's disease (ADAD) variant for which lecanemab response data are unavailable.

Min-Young Noh, Wonjae Sung, Hyunkee Kim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.